Mortality by cause for eight regions of the world: Global Burden of Disease Study.

PubWeight™: 29.18‹?› | Rank: Top 0.01% | All-Time Top 10000

🔗 View Article (PMID 9142060)

Published in Lancet on May 03, 1997

Authors

C J Murray1, A D Lopez

Author Affiliations

1: Harvard School of Public Health, Boston, Massachusetts, USA.

Associated clinical trials:

Evaluation of PTB Screening in ANC in Lusaka, Zambia | NCT02053129

Efficacy Study on Symptomatic Control of Patient With Knee Osteoarthritis Between 14% of Plai (Plaivana®) to Placebo Gels (OA knee Plai) | NCT01836393

Post-Injury Platelet Biology: Mechanisms and Outcomes | NCT03682757

Articles citing this

(truncated to the top 100)

The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature (2005) 31.73

The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis (2004) 14.42

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ (2000) 8.53

Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax (2005) 7.39

Estimating the global clinical burden of Plasmodium falciparum malaria in 2007. PLoS Med (2010) 7.22

The burden of malaria mortality among African children in the year 2000. Int J Epidemiol (2006) 6.64

The Global Burden of Cancer 2013. JAMA Oncol (2015) 5.93

Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet (2008) 5.49

Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA (2009) 5.32

Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J Clin Microbiol (2000) 5.01

Earth observation, geographic information systems and Plasmodium falciparum malaria in sub-Saharan Africa. Adv Parasitol (2000) 4.92

The accuracy of human population maps for public health application. Trop Med Int Health (2005) 4.64

Estimates of global and regional smoking prevalence in 1995, by age and sex. Am J Public Health (2002) 4.22

Epidemiology of sudden cardiac death: clinical and research implications. Prog Cardiovasc Dis (2008) 4.09

Safety in numbers: more walkers and bicyclists, safer walking and bicycling. Inj Prev (2003) 4.01

Injury patterns in rural and urban Uganda. Inj Prev (2001) 3.81

Urbanization, urbanicity, and health. J Urban Health (2002) 3.79

From what will we die in 2020? Lancet (1997) 3.37

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet (2016) 3.31

Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer (2002) 3.26

Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol (2010) 3.23

Cardiovascular and cancer mortality among Canadians of European, south Asian and Chinese origin from 1979 to 1993: an analysis of 1.2 million deaths. CMAJ (1999) 3.18

A checklist for health research priority setting: nine common themes of good practice. Health Res Policy Syst (2010) 3.14

Hypertension treatment and control in sub-Saharan Africa: the epidemiological basis for policy. BMJ (1998) 2.93

Mortality in the Islamic Republic of Iran, 1964-2004. Bull World Health Organ (2007) 2.93

A study of national physician organizations' efforts to reduce racial and ethnic health disparities in the United States. Acad Med (2012) 2.83

Algorithms for enhancing public health utility of national causes-of-death data. Popul Health Metr (2010) 2.67

Antimicrobial resistance in developing countries. BMJ (1998) 2.61

The global burden of unintentional injuries and an agenda for progress. Epidemiol Rev (2010) 2.61

Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. Ann Neurol (2009) 2.55

Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. J Exp Med (2006) 2.54

STAT protein interference and suppression of cytokine signal transduction by measles virus V protein. J Virol (2003) 2.54

A national burden of disease calculation: Dutch disability-adjusted life-years. Dutch Burden of Disease Group. Am J Public Health (2000) 2.49

SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 2.49

The burden of disease profile of residents of Nairobi's slums: results from a demographic surveillance system. Popul Health Metr (2008) 2.43

Citywide trauma experience in Kampala, Uganda: a call for intervention. Inj Prev (2002) 2.43

Measles virus structural components are enriched into lipid raft microdomains: a potential cellular location for virus assembly. J Virol (2000) 2.40

Management of bleeding following major trauma: a European guideline. Crit Care (2007) 2.40

Population based prevalence of high blood pressure among adults in Addis Ababa: uncovering a silent epidemic. BMC Cardiovasc Disord (2009) 2.37

Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart (2002) 2.34

Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost. Int J Cancer (2004) 2.31

Genetic variation in SCN10A influences cardiac conduction. Nat Genet (2010) 2.30

The influence of urbanisation on measures of Plasmodium falciparum infection prevalence in East Africa. Acta Trop (2005) 2.23

Estimating deaths from cardiovascular disease: a review of global methodologies of mortality measurement. Circulation (2013) 2.22

Randomized, controlled trial of an interactive videodisc decision aid for patients with ischemic heart disease. J Gen Intern Med (2000) 2.21

Do lifestyle interventions work in developing countries? Findings from the Isfahan Healthy Heart Program in the Islamic Republic of Iran. Bull World Health Organ (2009) 2.16

Will China's nutrition transition overwhelm its health care system and slow economic growth? Health Aff (Millwood) (2008) 2.15

A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice. Am J Pathol (2002) 2.02

Measuring the efficiency of health systems. The world health report sets the agenda, but there's still a long way to go. BMJ (2001) 2.02

Can medicine prevent war? Imaginative thinking shows that it might. BMJ (1999) 1.95

Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation. Am J Pathol (1999) 1.87

Peripheral nociception associated with surgical incision elicits remote nonischemic cardioprotection via neurogenic activation of protein kinase C signaling. Circulation (2009) 1.86

Comparison of cardiovascular risk profiles among ethnic groups using population health surveys between 1996 and 2007. CMAJ (2010) 1.85

Occupational therapy for patients with problems in personal activities of daily living after stroke: systematic review of randomised trials. BMJ (2007) 1.85

Cohort profile: the 2004 Pelotas (Brazil) birth cohort study. Int J Epidemiol (2010) 1.80

A 10 year study of the cause of death in children under 15 years in Manhiça, Mozambique. BMC Public Health (2009) 1.76

The calcium sensor STIM1 is an essential mediator of arterial thrombosis and ischemic brain infarction. J Exp Med (2008) 1.74

The burden of acute respiratory infections in crisis-affected populations: a systematic review. Confl Health (2010) 1.72

A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids. Br J Pharmacol (2007) 1.71

Exploring the impact of foreign direct investment on tobacco consumption in the former Soviet Union. Tob Control (2005) 1.71

Hypoxaemia in acute respiratory and non-respiratory illnesses in neonates and children in a developing country. Arch Dis Child (2002) 1.71

The application of geographical information systems to important public health problems in Africa. Int J Health Geogr (2002) 1.70

Antimalarial drug quality in Africa. J Clin Pharm Ther (2007) 1.68

Occupational class and ischemic heart disease mortality in the United States and 11 European countries. Am J Public Health (1999) 1.68

Large-scale spatial population databases in infectious disease research. Int J Health Geogr (2012) 1.68

Randomised controlled trials in psychiatry: important but poorly accepted. BMJ (1999) 1.67

Patterns of violence in Karachi, Pakistan. Inj Prev (2002) 1.64

Surveillance of cardiovascular disease risk factors in India: the need & scope. Indian J Med Res (2010) 1.64

Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase. Blood (2005) 1.62

HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health (2009) 1.62

Trends in mortality from major diseases in Europe, 1980-1993. Eur J Epidemiol (1998) 1.59

Assessing the burden of injury in six European countries. Bull World Health Organ (2007) 1.58

Major cardiovascular risk factors in Latin America: a comparison with the United States. The Latin American Consortium of Studies in Obesity (LASO). PLoS One (2013) 1.56

Peakwide mapping on chromosome 3q13 identifies the kalirin gene as a novel candidate gene for coronary artery disease. Am J Hum Genet (2007) 1.55

A ferret model of canine distemper virus virulence and immunosuppression. J Virol (2003) 1.55

A community programme to reduce salt intake and blood pressure in Ghana [ISRCTN88789643]. BMC Public Health (2006) 1.55

Deconstructing the differences: a comparison of GBD 2010 and CHERG's approach to estimating the mortality burden of diarrhea, pneumonia, and their etiologies. BMC Infect Dis (2015) 1.54

Blood pressure patterns in rural, semi-urban and urban children in the Ashanti region of Ghana, West Africa. BMC Public Health (2005) 1.49

Progesterone in experimental permanent stroke: a dose-response and therapeutic time-window study. Brain (2013) 1.49

Impaired alpha(IIb)beta(3) integrin activation and shear-dependent thrombus formation in mice lacking phospholipase D1. Sci Signal (2010) 1.49

Socioeconomic status and ischaemic heart disease mortality in 10 western European populations during the 1990s. Heart (2005) 1.48

Ten-year change in blood pressure levels and prevalence of hypertension in urban and rural Cameroon. J Epidemiol Community Health (2009) 1.47

Level of urbanization and noncommunicable disease risk factors in Tamil Nadu, India. Bull World Health Organ (2009) 1.47

Mapping the environmental coverage of the INDEPTH demographic surveillance system network in rural Africa. Trop Med Int Health (2006) 1.45

Socioeconomic inequalities in non-communicable diseases prevalence in India: disparities between self-reported diagnoses and standardized measures. PLoS One (2013) 1.45

Risk factor profile for chronic kidney disease is similar to risk factor profile for small artery disease. J Hypertens (2011) 1.45

Principles help to analyse but often give no solution--secondary prevention after a cardiac event. Health Care Anal (2006) 1.44

Body mass index and mortality in chronic obstructive pulmonary disease: a meta-analysis. PLoS One (2012) 1.44

Arsenic exposure and hypertension: a systematic review. Environ Health Perspect (2011) 1.44

Ischaemic stroke: the ocular motor system as a sensitive marker for motor and cognitive recovery. J Neurol Neurosurg Psychiatry (2012) 1.43

An alternate pathway for androgen regulation of brain function: activation of estrogen receptor beta by the metabolite of dihydrotestosterone, 5alpha-androstane-3beta,17beta-diol. Horm Behav (2007) 1.43

Low serum high density lipoprotein cholesterol concentration is an independent predictor for enhanced inflammation and endothelial activation. PLoS One (2015) 1.42

A randomized controlled trial of information-giving to patients referred for coronary angiography: effects on outcomes of care. Health Expect (1998) 1.42

Human bocavirus infection among children, Jordan. Emerg Infect Dis (2006) 1.40

Cardiovascular disease mortality and its association with socioeconomic status: findings from a population-based cohort study in rural Vietnam, 1999-2003. Prev Chronic Dis (2006) 1.38

Comparison of estimates and calculations of risk of coronary heart disease by doctors and nurses using different calculation tools in general practice: cross sectional study. BMJ (2002) 1.37

Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data. BMC Health Serv Res (2011) 1.36

Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke. Ann Neurol (2005) 1.36

Morbidity among HIV-1-infected mothers in Kenya: prevalence and correlates of illness during 2-year postpartum follow-up. J Acquir Immune Defic Syndr (2007) 1.35

BRIC's Growing Share of Global Health Spending and Their Diverging Pathways. Front Public Health (2015) 1.35

Articles by these authors

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet (1997) 44.03

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet (1997) 25.40

Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet (1992) 25.28

Evidence-based health policy--lessons from the Global Burden of Disease Study. Science (1996) 13.50

Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med (1997) 8.25

Mortality from smoking worldwide. Br Med Bull (1996) 7.87

Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study. Lancet (1997) 7.29

The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ (1994) 6.99

The global burden of disease, 1990-2020. Nat Med (1998) 6.50

Quantifying disability: data, methods and results. Bull World Health Organ (1994) 4.99

Measuring the accumulated hazards of smoking: global and regional estimates for 2000. Tob Control (2003) 4.94

Armed conflict as a public health problem. BMJ (2002) 4.42

Healthy life expectancy in 191 countries, 1999. Lancet (2001) 4.31

On the comparable quantification of health risks: lessons from the Global Burden of Disease Study. Epidemiology (1999) 3.66

The decline in child mortality: a reappraisal. Bull World Health Organ (2000) 3.46

Global and regional cause-of-death patterns in 1990. Bull World Health Organ (1994) 3.37

Progress and directions in refining the global burden of disease approach: a response to Williams. Health Econ (2000) 3.17

The use of cause-of-death statistics for health situation assessment: national and international experiences. World Health Stat Q (1990) 2.84

The utility of DALYs for public health policy and research: a reply. Bull World Health Organ (1997) 2.49

Regional, disease specific patterns of smoking-attributable mortality in 2000. Tob Control (2004) 2.12

Measuring the burden of disease. Lancet (1998) 1.58

At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer (1994) 1.45

Hypertension in developing countries. World Health Stat Q (1988) 1.45

Sustained proliferation of PDX-1+ cells derived from human islets. Diabetes (1999) 1.35

Ex vivo expansion of human pancreatic endocrine cells. J Clin Endocrinol Metab (1997) 1.33

Tobacco or health. World Health Stat Q (1993) 1.32

KSA antigen Ep-CAM mediates cell-cell adhesion of pancreatic epithelial cells: morphoregulatory roles in pancreatic islet development. J Cell Biol (1998) 1.26

Global and regional mortality patterns by cause of death in 1980. Int J Epidemiol (1986) 1.22

Global gene expression profiling and histochemical analysis of the developing human fetal pancreas. Diabetologia (2007) 1.21

An in vivo model for study of the angiogenic effects of basic fibroblast growth factor. Biochem Biophys Res Commun (1987) 1.19

Accelerated telomere shortening and senescence in human pancreatic islet cells stimulated to divide in vitro. J Endocrinol (2000) 1.18

Counting the dead in China. Measuring tobacco's impact in the developing world. BMJ (1998) 1.14

Growth factor/matrix-induced proliferation of human adult beta-cells. Diabetes (1995) 1.13

The incremental effect of age-weighting on YLLs, YLDs, and DALYs: a response. Bull World Health Organ (1996) 1.09

Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes (1994) 1.08

On the assessment of maternal mortality. World Health Stat Q (1987) 1.04

A role for activin A and betacellulin in human fetal pancreatic cell differentiation and growth. J Clin Endocrinol Metab (2000) 1.03

Trehalose: a cryoprotectant that enhances recovery and preserves function of human pancreatic islets after long-term storage. Diabetes (1997) 1.02

Sex differentials in mortality. WHO Chron (1984) 1.02

Functional beta-cell mass after transplantation of human fetal pancreatic cells: differentiation or proliferation? Diabetes (1997) 1.00

Reducing child mortality. Bull World Health Organ (2000) 0.94

Isolation and characterization of a cell line from the epithelial cells of the human fetal pancreas. Cell Transplant (1997) 0.92

Epidemiologic surveillance of the tobacco epidemic. MMWR Morb Mortal Wkly Rep (1992) 0.91

Keratinocyte growth factor and beta-cell differentiation in human fetal pancreatic endocrine precursor cells. Diabetologia (2003) 0.89

Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes (1999) 0.88

Developmental gene expression in the human fetal pancreas. Pediatr Res (1994) 0.86

Decrease in the number of neonatal islets required for successful transplantation by strict metabolic control of diabetic rats. Transplantation (1988) 0.85

Smoking and death in Russia. Tob Control (1998) 0.84

A note on estimating the cause of death structure in high mortality populations. Popul Bull UN (1982) 0.83

Factors influencing islet transplantation. Number, location, and metabolic control. Transplantation (1990) 0.83

Protection from cell death in cultured human fetal pancreatic cells. Cell Transplant (2000) 0.81

The use of digital image processing to quantitate angiogenesis induced by basic fibroblast growth factor and transplanted pancreatic islets. Microvasc Res (1991) 0.81

Tuberculosis mortality differentials in Indonesia during 2007-2008: evidence for health policy and monitoring. Int J Tuberc Lung Dis (2011) 0.80

Transplantation of human fetal pancreas: fresh vs. cultured fetal islets or ICCS. J Mol Med (Berl) (1999) 0.80

100 years of mortality due to chronic obstructive pulmonary disease in Australia: the role of tobacco consumption. Int J Tuberc Lung Dis (2012) 0.79

Enhancement of pancreatic islet cell monolayer growth by endothelial cell matrix and insulin. In Vitro Cell Dev Biol (1989) 0.79

Development of a cell line from the human fetal pancreas. Transplant Proc (1995) 0.78

Analysis of a human fetal pancreatic islet cell line. Transplant Proc (1997) 0.78

Maturation and function of human fetal pancreatic cells after cryopreservation. Transplantation (1993) 0.78

International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the United States. Ann N Y Acad Sci (1990) 0.77

Health for all: analyzing health status and determinants. World Health Stat Q (1998) 0.77

Use of hepatocyte growth factor/scatter factor to increase transplantable human fetal islet cell mass. Transplant Proc (1994) 0.77

Angiogenic peptides in pancreatic islet transplantation to diabetic rats. Transplantation (1990) 0.76

In vivo maturation and growth potential of human fetal pancreases: fresh versus cultured tissue. Transplant Proc (1995) 0.76

Investigating Australia's burden of disease. Med J Aust (2000) 0.75

Health outlook for South and East Asia for the year 2000. World Health Stat Q (1981) 0.75

[Preventable deaths: general view]. World Health Stat Q (1989) 0.75

The impact of demographic trends on health: introduction. World Health Stat Q (1987) 0.75

Changing grassroots perception on the family. Rural Reconstr Forum (1995) 0.75

Using national mortality data to study the changing sex differential in mortality. Soz Praventivmed (1984) 0.75

Mortality patterns and trends among the elderly in developed countries. World Health Stat Q (1982) 0.75

Health projections. Introduction. World Health Stat Q (1984) 0.75

Generation of viable isletlike cell clusters from cryopreserved human fetal pancreas. Transplant Proc (1992) 0.75